Breast Cancer

Top Story

Better understanding of disease biology triggers ‘revolution’ in male breast cancer

Better understanding of disease biology triggers ‘revolution’ in male breast cancer
HemOnc Today, June 25, 2016

Breast cancer is the most common malignancy in the United States.

It also is the most highly funded, accounting for nearly one-sixth of NCI’s annual research budget.

In the Journals

Increased awareness, expanded trial access ‘could save lives’ of men with breast cancer

HemOnc Today, June 25, 2016
Like most men, Oliver Bogler, PhD, never worried about his risk for breast cancer. Even when Bogler — a cancer biologist — felt a lump in his right breast…
In the Journals

Outcomes, treatment strategies vary among patients with upper extremity venous thrombosis

June 24, 2016
The risk for recurrent venous thromboembolism appeared low for patients with upper extremity deep vein thrombosis and almost nonexistent for patients with upper…
At IssueVideo

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at MD Anderson Cancer Center in Houston, discusses…
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video
Meeting News Coverage

VIDEO: I-SPY 2 results suggest potential for new standard in HER-2–positive breast cancer

May 6, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Cover Story

Better understanding of disease biology triggers ‘revolution’ in male breast cancer

HemOnc Today, June 25, 2016
Breast cancer is the most common malignancy in the United States. It also is the most highly funded, accounting for nearly one-sixth of NCI’s…

In the Journals

Increased awareness, expanded trial access ‘could save lives’ of men with breast cancer

HemOnc Today, June 25, 2016
Like most men, Oliver Bogler, PhD, never worried about his risk for breast cancer. Even when Bogler — a cancer biologist — felt a lump…

In the Journals

Outcomes, treatment strategies vary among patients with upper extremity venous thrombosis

June 24, 2016
The risk for recurrent venous thromboembolism appeared low for patients with upper extremity deep vein thrombosis and almost nonexistent for patients…

At IssueVideo

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at MD Anderson Cancer Center in…

In the Journals

Candesartan fails to reduce left ventricular ejection fraction in early-stage breast cancer

June 23, 2016
The concomitant use of candesartan during or after trastuzumab therapy failed to protect against left ventricular ejection fraction in women with…

Meeting News CoverageVideo

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can…

Meeting News CoverageVideo

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
CHICAGO — Dawn L. Hershman, MD, MS, associate professor of medicine at Columbia University Medical Center, reviews study results that…

In the Journals

Mutation status may guide endocrine therapy for advanced breast cancer

June 22, 2016
Plasma analysis of ESR1 mutations may aid in the identification of appropriate endocrine therapy for patients with advanced breast cancer who…

Meeting News CoverageVideo

VIDEO: MA.17R trial shows ‘clear benefit’ of extended hormonal therapy

June 21, 2016
CHICAGO — Ron Bose, MD, PhD, medical oncologist at Washington University School of Medicine in St. Louis, reviews the positive results from…

In the Journals

Almost one-third of breast cancer cases traced to modifiable behavior

June 20, 2016
Recent study data published in JAMA Oncology suggest that 29% of breast cancer cases among white women in the United States could be prevented if…

More Headlines »
morganatic-roan
morganatic-roan